Oruka Therapeutics, Inc. (ORKA) Live Share Price, Invest From India

Oruka Therapeutics, Inc. Stock Performance

as on May 5, 2026 at 6:59 am IST

Day's Low
Day's High
$60.98
Day's Price Range
$66.60
$66.52
8.33%
Downside
0.12%
Upside
52 Week's Low
52 Week's High
$8.91
52-Week Price Range
$91.00
$66.52
86.61%
Downside
36.80%
Upside

Oruka Therapeutics, Inc. share price movements today

Previous Close: $62.58
Open: $61.40
Volume: 2.2M
Day's Low - High: $60.98 - $66.60
52 Week Low - High: $8.91 - $91.00

Oruka Therapeutics, Inc. Historical Returns

1 Month Return: + 17.39 %
3 Month Return: + 89.64 %
1 Year Return: + 484.31 %
3 Year Return: 0 %
5 Year Return: 0 %

Oruka Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Oruka Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.7B

EPS (TTM)

-2.1569

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-24.69%

Oruka Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Oruka Therapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Oruka Therapeutics, Inc.	NA	$3.7B	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$39.5B	125.06%	74.59	12.55%
Vertex Pharmaceuticals Inc	BUY	$107.8B	97.31%	27.71	32.94%
BeiGene, Ltd.	NA	$32.7B	NA	118.97	5.37%
Regeneron Pharmaceuticals Inc	BUY	$73.5B	44.57%	17.12	29.65%

Stock Returns calculator for Oruka Therapeutics, Inc. Stock including INR - Dollar returns

The Oruka Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Oruka Therapeutics, Inc. investment value today

Current value as on today

₹7,00,476

Returns

₹6,00,476

(+600.48%)

Returns from Oruka Therapeutics, Inc. Stock

₹5,21,102 (+521.1%)

Dollar Impact

₹79,374 (+79.37%)

Oruka Therapeutics, Inc. Stock’s Investor Sentiment and Interest

Search interest for Oruka Therapeutics, Inc. Stock has increased by 518% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 5, 2026 to May 5, 2026

Change:518% versus previous 30 day period

Oruka Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	-	0
Operating Income	-2	-21	-29	-25	-28	-34	-34
EBITDA	-1	-22	-28	-20	-24	-30	-34
Interest Expense	0	0	0	-	-	-	-
Depreciation	-	-	-	0	0	0	0
Income Before Tax	-2	-22	-28	-20	-24	-30	-29
Income Tax Expense	-	-	-	-	-	-	-
Net Income	-2	-22	-28	-20	-24	-30	-29
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Oruka Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2025
Total Revenue	-
Gross Profit	0
Operating Income	-122
EBITDA	-121
Interest Expense	-
Depreciation	0
Income Before Tax	-105
Income Tax Expense	-
Net Income	-105
Net Profit Margin	0.00%

Oruka Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2022	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-3	-7	-2	-28	-25	-20	-24	-30	-29
Operating Cash Flow	-4	0	-2	-34	-18	-20	-23	-21	-22
Investing Cash Flow	0	-	-	0	-329	42	4	-122	-22
Financing Cash Flow	-	27	0	450	0	-	0	169	0
Change in Cash	-4	27	-2	377	-349	21	-18	25	-44

Oruka Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2024	Dec 2025
Net Income	-16	-18	-7	-5	-9	-19	-9	-83	-105
Operating Cash Flow	-14	-17	-8	-4	-7	-18	-10	-57	-88
Investing Cash Flow	-16	12	3	0	0	0	0	-330	-96
Financing Cash Flow	-	5	3	6	48	23	-	449	170
Change in Cash	-31	1	-2	1	40	4	-10	24	-14

Insights on Oruka Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, ORKA has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, ORKA has outperformed top 5 stocks with highest market-cap in its industry
NEGATIVE IMPACT
Price Dip
In the last 7 days, ORKA stock has moved down by -18.1%

About Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.

Organisation	Oruka Therapeutics, Inc.
Headquarters	855 Oak Grove Avenue, Menlo Park, CA, United States, 94025
Industry	Biotechnology
CEO	Dr. Lawrence Otto Klein Ph.D.
E-voting on shares	Click here to vote

Key Management of Oruka Therapeutics, Inc.

Name	Title
Mr. Christopher Finch	Senior VP and Head of Business Development & Strategy
Dr. Rajiv Panwar	Senior VP and Head of Chemistry, Manufacturing & Controls
Dr. Lawrence Otto Klein Ph.D.	President, CEO & Director
Mr. Paul T. Quinlan	General Counsel & Secretary
Dr. Joana Goncalves M.D.	Chief Medical Officer
Mr. Arjun Agarwal CPA	Senior VP of Finance & Treasurer
Ms. Laura Sandler	Chief Operating Officer
Mr. Alan Lada	VP of IR & Capital Markets

FAQs

What is Oruka Therapeutics, Inc. share price today?

Oruka Therapeutics, Inc. share price today is $66.52 as on May 5, 2026 at 1:29 am IST at the close of the market. Oruka Therapeutics, Inc. share today touched a day high of $66.6 and a low of $60.98.

What is the 52 week high and 52 week low for Oruka Therapeutics, Inc. share?

Oruka Therapeutics, Inc. share touched a 52 week high of $91 on April 27, 2026 and a 52 week low of $8.91 on May 15, 2025. Oruka Therapeutics, Inc. stock price today i.e. May 5, 2026 at 1:29 am IST is closed at $66.52,which is 26.90% down from its 52 week high and 646.58% up from its 52 week low.

What is Oruka Therapeutics, Inc.'s market capitalisation today?

Oruka Therapeutics, Inc. market capitalisation is $0.00T as on May 5, 2026 at 1:29 am IST.

How to invest in Oruka Therapeutics, Inc. Stock (ORKA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Oruka Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Oruka Therapeutics, Inc. Shares that will get you 0.0225 shares as per Oruka Therapeutics, Inc. share price of $66.52 per share as on May 5, 2026 at 1:29 am IST.

What is the minimum amount required to buy Oruka Therapeutics, Inc. Stock (ORKA) from India?

Indian investors can start investing in Oruka Therapeutics, Inc. (ORKA) shares with as little as ₹95.067 or $1 (as of May 5, 2026 at 1:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹950.67 in Oruka Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on May 5, 2026 at 1:43 am IST). Based on Oruka Therapeutics, Inc. share’s latest price of $66.52 as on May 5, 2026 at 1:29 am IST, you will get 0.1503 shares of Oruka Therapeutics, Inc.. Learn more about fractional shares .